Role of Imaging in the Diagnosis and Monitoring of Neurological Conditions

Description

How can imaging improve the treatment of movement disorders, epilepsy, and dementias, including Alzheimer’s disease? Find out from some of the nation’s preeminent experts in nuclear and geriatric medicine. You’ll learn about the pathologies underlying the specific neurological disorders, the mechanism of action for the imaging biomarkers, and the role of imaging in the clinical management of the disorder.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Describe the role of I-123 Ioflupane imaging in the management of movement disorders.
  2. Describe the application of imaging biomarkers in Alzheimer’s disease and other related dementias.
  3. Describe the role of imaging in the management of epilepsy.
 
 
 
Speakers:
David
David Lewis, MD
Professor
University of Washington
 
Learning Level: Level 2
Track: Nuclear Pharmacy
Session Time Slot(s): 
Date: 
Friday, March 20
Time: 
2:00 PM - 5:00 PM
Room: 
Gaylord National Resort - Chesapeake A-C
CEUs Pharmacist: 0.3
Activity Type:
Knowledge-based